CRISPR Therapeutics AG (CRSP) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$4,619
Total Return
-53.81%
CAGR
-14.32%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.17% |
| Median | -2.41% |
| Best | +86.90% |
| Worst | -32.39% |
| % of Windows Positive | 41.8% |
1-Year (252 Trading Days)
| Average | -8.34% |
| Median | -13.51% |
| Best | +85.59% |
| Worst | -62.37% |
| % of Windows Positive | 38.8% |
3-Year (756 Trading Days)
| Average | -26.95% |
| Median | -31.61% |
| Best | +44.28% |
| Worst | -67.20% |
| % of Windows Positive | 23.2% |
Risk Metrics
| Maximum Drawdown | -80.68% |
| Average Drawdown | -60.26% |
| Drawdown Duration | 1200 Trading Days (Unrecovered) |
| Sortino Ratio | 0.06 |
| Calmar Ratio | -0.18 |
| CVaR (5%) | -7.33% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +8.43% (+32.87% ann.) | +$842.87 | $0.00 | $0.00 | $0.00 |
| 2025 | +33.23% | +$3323.17 | $0.00 | $0.00 | $0.00 |
| 2024 | -37.12% | $3712.46 | $0.00 | $0.00 | $0.00 |
| 2023 | +54.00% | +$5399.75 | $0.00 | $0.00 | $0.00 |
| 2022 | -46.36% | $4635.79 | $0.00 | $0.00 | $0.00 |
| 2021 | -50.51% | $5050.62 | $0.00 | $0.00 | $0.00 |
| 2020 | +151.39% | +$15139.15 | $0.00 | $0.00 | $0.00 |
| 2019 | +113.18% | +$11317.82 | $0.00 | $0.00 | $0.00 |
| 2018 | +21.68% | +$2167.80 | $0.00 | $0.00 | $0.00 |
| 2017 | +15.89% | +$1589.34 | $0.00 | $0.00 | $0.00 |
| 2016 partial | +43.79% (+531.17% ann.) | +$4378.99 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | October 19, 2016 – February 19, 2020 | +312.42% | +52.94% | +$31242.02 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -30.34% | -98.39% | $3033.83 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +140.65% | +310.82% | +$14064.70 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -21.75% | -20.76% | $2174.61 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -38.76% | -40.59% | $3876.09 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -8.81% | -4.86% | $881.33 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +14.66% | +9.11% | +$1466.02 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.